Page 25 - Personalised medicine of fluoropyrimidines using DPYD pharmacogenetics Carin Lunenburg
P. 25
CHAPTER 2
Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: ready for prime time
Eur J Cancer. 2016;54:40-8
Carin A.T.C. Lunenburg, Linda M. Henricks, Henk-Jan Guchelaar, Jesse J. Swen, Maarten J. Deenen, Jan H.M. Schellens, Hans Gelderblom
